Exploration of the Link Between COVID-19 and Alcoholic Hepatitis from the Perspective of Bioinformatics and Systems Biology

Objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been suggested to purpose threats to health of mankind. Alcoholic hepatitis (AH) is a life-threatening acute and chronic liver failure that takes place in sufferers who drink excessively. During the epidemic, AH has an increasing incidence of severe illness and mortality. However, for these two diseases, the intrinsic relationship of molecular pathogenesis, as well as common therapeutic strategies are still poorly understood. Methods The transcriptome of the COVID-19 and AH has been compared to obtain the altered genes and hub genes were screened out through protein-protein interaction (PPI) network analysis. Via gene ontology (GO), pathway enrichment and transcription regulator analysis, a deeper appreciation of the interplay mechanism between hub genes were established. Results With 181 common differentially expressed genes (DEGs) of AH and COVID-19 were obtained, 10 hub genes were captured. Follow-up studies located that these 10 genes typically mediated the diseases occurrence by regulating the activities of the immune system. Other results suggest that the common pathways of the two ailments are enriched in regulating the function of immune cells and the release of immune molecules. Conclusion This study reveals the common pathogenesis of COVID-19 and AH and assist to discover necessary therapeutic targets to combat the ongoing pandemic induced via SARS-CoV-2 infection and acquire promising remedy strategies for the two diseases.

[1]  Lee M. Tatham,et al.  FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 , 2022, Nature.

[2]  D. Bruzzese,et al.  Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status , 2022, Frontiers in Medicine.

[3]  R. Gui,et al.  Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach , 2022, Frontiers in Immunology.

[4]  Yimeng Wang,et al.  Transcriptome Analysis Reveals Hub Genes Regulating Autophagy in Patients With Severe COVID-19 , 2022, Frontiers in genetics.

[5]  Md. Nurul Haque Mollah,et al.  Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches , 2022, PloS one.

[6]  Facai Zhang,et al.  Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis , 2022, Frontiers in Immunology.

[7]  Wei Hu,et al.  Dissecting the single-cell transcriptomeunderlying chronic liver injury , 2021, Molecular therapy. Nucleic acids.

[8]  Yulin Zou,et al.  Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19 , 2021, Journal of inflammation research.

[9]  K. Khunti,et al.  COVID-19, Hyperglycemia, and New-Onset Diabetes , 2021, Diabetes Care.

[10]  C. Coffin,et al.  Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada , 2021, Clinical Gastroenterology and Hepatology.

[11]  K. Khunti,et al.  COVID-19 and metabolic disease: mechanisms and clinical management , 2021, The Lancet Diabetes & Endocrinology.

[12]  Zhi Chen,et al.  Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro , 2021, bioRxiv.

[13]  J. Saez-Rodriguez,et al.  Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activity , 2021, bioRxiv.

[14]  X. Bian,et al.  A cohort autopsy study defines COVID-19 systemic pathogenesis , 2021, Cell Research.

[15]  Muhammad Tariq Majeed,et al.  IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY. , 2021, Journal of hepatology.

[16]  S. Podder,et al.  Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity , 2021, Computers in Biology and Medicine.

[17]  Quynh P. Nguyen,et al.  Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection , 2021, Immunity.

[18]  Wenyu Chen,et al.  Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients , 2021, Briefings in bioinformatics.

[19]  Hyunsub Sim,et al.  CD11b Deficiency Exacerbates Methicillin-Resistant Staphylococcus aureus-Induced Sepsis by Upregulating Inflammatory Responses of Macrophages , 2021, Immune network.

[20]  W. Greene,et al.  Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 , 2021, medRxiv.

[21]  J. Tanner,et al.  The Fatty Acid Lipid Metabolism Nexus in COVID-19 , 2021, Viruses.

[22]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[23]  H. Akhavan-Niaki,et al.  Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations , 2020, Gene Reports.

[24]  D. Gupta,et al.  Identification of Novel SARS-CoV-2 Drug Targets by Host MicroRNAs and Transcription Factors Co-regulatory Interaction Network Analysis , 2020, Frontiers in Genetics.

[25]  B. Chernyak,et al.  NETosis: Molecular Mechanisms, Role in Physiology and Pathology , 2020, Biochemistry (Moscow).

[26]  D. Bander,et al.  Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report , 2020, The American journal of case reports.

[27]  Md. Rezanur Rahman,et al.  Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19 , 2020, European Journal of Pharmacology.

[28]  E. López-Collazo,et al.  Immune Response and COVID-19: A mirror image of Sepsis , 2020, International journal of biological sciences.

[29]  O. Franco,et al.  Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis , 2020, European Journal of Epidemiology.

[30]  Bruno Francois,et al.  Immunotherapies for COVID-19: lessons learned from sepsis , 2020, The Lancet Respiratory Medicine.

[31]  Jun Lyu,et al.  Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection , 2020, International Journal of Infectious Diseases.

[32]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[33]  Phillip A. Richmond,et al.  JASPAR 2020: update of the open-access database of transcription factor binding profiles , 2019, Nucleic Acids Res..

[34]  F. Sanz,et al.  The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..

[35]  Canty-Laird Extracellular matrix organization , 2020 .

[36]  E. Williams,et al.  Intermediate Monocytes in Acute Alcoholic Hepatitis Are Functionally Activated and Induce IL-17 Expression in CD4+ T Cells , 2019, The Journal of Immunology.

[37]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[38]  Miran Kim,et al.  Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model. , 2015, Journal of hepatology.

[39]  Jianguo Xia,et al.  NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data , 2015, Nature Protocols.

[40]  Chung-Yen Lin,et al.  cytoHubba: identifying hub objects and sub-networks from complex interactome , 2014, BMC Systems Biology.

[41]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[42]  Sébastien Matamoros,et al.  Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity , 2014, Proceedings of the National Academy of Sciences.

[43]  Hui Liu,et al.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies. , 2014, Experimental and molecular pathology.

[44]  Philippe Bardou,et al.  jvenn: an interactive Venn diagram viewer , 2014, BMC Bioinformatics.

[45]  Pietro Liò,et al.  comoR: a software for disease comorbidity risk assessment , 2014, Journal of Clinical Bioinformatics.

[46]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[47]  S. Jupe Assembly of collagen fibrils and other multimeric structures , 2012 .

[48]  Zheng Shen,et al.  MicroRNA-217 Promotes Ethanol-induced Fat Accumulation in Hepatocytes by Down-regulating SIRT1* , 2012, The Journal of Biological Chemistry.

[49]  P. Marcellin,et al.  Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C , 2011, International journal of hepatology.

[50]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[51]  Andrew J. Brown Viral hepatitis and fatty liver disease: how an unwelcome guest makes pâté of the host. , 2008, The Biochemical journal.

[52]  A. Hatzigeorgiou,et al.  TarBase: A comprehensive database of experimentally supported animal microRNA targets. , 2005, RNA.

[53]  Ching-lung Lai,et al.  SARS‐associated viral hepatitis caused by a novel coronavirus: Report of three cases , 2004, Hepatology.

[54]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[55]  J. M. Olmos,et al.  Impaired monocyte function in primary biliary cirrhosis. , 1988, Allergologia et immunopathologia.